Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Fluciclovine 18F (Primary)
Indications Germ cell and embryonal neoplasms; Germ cell cancer; Testicular cancer
Focus Diagnostic use
Acronyms TESTPET

01 Oct 2024 Planned End Date changed from 5 Jul 2024 to 5 Jul 2026.
01 Oct 2024 Planned primary completion date changed from 5 Jul 2024 to 5 Jul 2025.
02 Nov 2023 Planned End Date changed from 5 Jul 2023 to 5 Jul 2024.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com